Search

everythinglearnresearchcommunity

for

Search:↓

Early recognition and management of gastrointestinal tuberculosis in lupus patients are crucial to prevent complications.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Pregnancy can increase lupus activity, but careful planning and treatment can improve outcomes.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

Fibromyalgia slightly more common in SLE patients but doesn't affect SLE activity assessments.

Some common medications can harm male fertility, but many effects can be reversed.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

Autoimmune diseases can cause hair loss, and early treatment is important to prevent permanent damage.

People with pemphigus are more likely to have conditions like hypothyroidism, inflammatory bowel disease, and diabetes.

Pregnancy can change skin disease severity, with some conditions improving and others worsening, and treatment should balance benefits and fetal safety.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

The new FDA labeling rules provide more detailed drug safety information for pregnant and breastfeeding women, but more data is needed on the risks of many dermatologic drugs.

Adalimumab helped control a child's severe eye disease when other treatments failed.

Scalp involvement is common in pemphigus and can lead to hair loss, with the severity of scalp lesions linked to overall disease severity.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Belimumab effectively controls SLE disease activity and reduces steroid use.

Infectious cerebral vasculitis can be a severe complication of meningoencephalitis, regardless of the pathogen.

Early detection and infection prevention are crucial for improving survival in pediatric lupus patients with aplastic anemia.

JSLE patients often have more hormone and metabolism issues, so regular check-ups and preventing obesity can help.

Genetically at-risk healthy people show similar immune issues as those with Pemphigus vulgaris or Alopecia areata.

A child with low platelets and anemia was later found to have lupus.

Different types of alopecia cause hair loss due to immune system issues, with some allowing regrowth and others causing permanent loss.

Gender-specific analysis could improve treatment for childhood systemic lupus erythematosus.

Rhupus is a complex syndrome that is hard to diagnose due to unclear clinical criteria.